Search results
2 days ago · The Medicines and Healthcare products Regulatory Agency (MHRA) has on 25 September approved leniolisib phosphate (Joenja) to treat a rare immune disease known as activated phosphoinositide 3 ...
- MHRA approves Spikevax JN.1 COVID-19 vaccines for ... - GOV.UK
On 2 September 2024, The Medicines and Healthcare products...
- MHRA approves Spikevax JN.1 COVID-19 vaccines for ... - GOV.UK
Sep 2, 2024 · On 2 September 2024, The Medicines and Healthcare products Regulatory Agency (MHRA) approved an adapted Moderna COVID-19 vaccine (Spikevax) that targets the JN.1 COVID-19 subvariant. This vaccine...
Sep 9, 2024 · MHRA is a UK agency that regulates medicines and medical devices. Learn about its governance, board, executive committee, terms of reference, minutes and meetings.
4 days ago · MHRA delegates at the 26 th Session of the International Medical Device Regulators Forum (IMDRF). Our external engagement on the programme of regulatory changes for medical devices has re-started in earnest this week following the pre-election period and early discussions with new ministers.
4 days ago · On 9 January 2024, the Medicines and Healthcare products Regulatory Agency (MHRA) published its Roadmap for the delivery of the future regulatory framework for medical devices.
1 day ago · The UK medicines regulator has launched its mutual recognition framework for authorising medicines in a move that it says will help to bring new drugs to patients in the UK more quickly.
Sep 3, 2024 · Moderna Receives Medicines And Healthcare Products Regulatory Agency (MHRA) Authorization For Updated COVID-19 Vaccine Targeting SARS-COV-2 Variant JN.1. Approval follows recommendation from global public health bodies to develop JN.1 COVID-19 vaccines.
